Anaesthetic Management of Emergency Spine Surgery with Patient on Dual Antiplatelet Agents

Authors

  •   Vidhu Bhatnagar Department of Anesthesiology and Critical Care, INHS Asvini, Mumbai, Maharashtra
  •   Deepak Dwivedi Department of Anesthesiology and Critical Care, INHS Asvini, Mumbai, Maharashtra
  •   Kavitha Jinjil Department of Anesthesiology and Critical Care, INHS Asvini, Mumbai, Maharashtra
  •   Shatabdi Chakraborty Department of Anesthesiology and Critical Care, INHS Asvini, Mumbai, Maharashtra

Keywords:

Drug‑eluting stents, platelet aggregation inhibitors, neurosurgical procedure, thromboelastography, thrombosis

Abstract

Antiplatelet therapy plays an important role in the management of coronary artery disease (CAD) patients, which include the spectrum of patients with stents in situ and those suffering from acute coronary syndrome (ACS) on medical management. The percentage of patients with stents in situ, scheduled for surgery within 2 years, is approximately 5–15%. The antiplatelet therapy predisposes patients to an increased risk of bleeding in the perioperative region, which can lead to fatal outcomes in spinal or intracranial surgeries; the problem multiplies manifolds if the surgery has to be performed in an emergency situation. We report a case of a 76‑year‑old lady, a known case of CAD with drug eluting stent in situ, on dual antiplatelet agents who had presented to our hospital with progressive weakness of lower limbs and had to be operated on the spine in emergency situation.

Downloads

Download data is not yet available.

Downloads

Published

2016-07-01

How to Cite

Bhatnagar, V., Dwivedi, D., Jinjil, K., & Chakraborty, S. (2016). Anaesthetic Management of Emergency Spine Surgery with Patient on Dual Antiplatelet Agents. Karnataka Anaesthesia Journal, 2(3), 99–101. Retrieved from http://karnatakaanesthesiajournal.in/index.php/kaj/article/view/139204

Issue

Volume 2, Issue 3, July-September 2016

Section

Case Reports

References

Newsome LT, Kutcher MA, Royster RL. Coronary artery stents: Part I Evolution of percutaneous coronary intervention. Anesth Analg 2008;107:552‑69.

Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL.Coronary artery stents: II. Perioperative considerations and management.Anesth Analg 2008;107:570‑90.

Berger PB, Kleiman NS, Pencina MJ, Hsieh WH, Steinhubl SR, Jeremias A, et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug‑eluting stent placement results from the EVENT (Evaluation of Drug‑Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv 2010;3:920‑7.

Gandhi NK, Abdel‑Karim AR, Banerjee S, Brilakis ES. Frequency and risk of noncardiac surgery after drug‑eluting stent implantation.Catheter Cardiovasc Interv 2011;77:972‑6.

Brilakis ES, Banerjee S, Berger PB. The risk of drug‑eluting stent thrombosis with noncardiac surgery. Curr Cardiol Rep 2007;9:406‑11.

Conroy M, Bolsin SN, Black SA, Orford N. Perioperative complications in patients with drug‑eluting stents: A three‑year audit at Geelong Hospital. Anaesth Intensive Care 2007;35:939‑44.

Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: The case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesthesiol 2007;99:316‑28.

Armstrong G, Zeng I, Webster MW. Noncardiac surgery and bleeding after percutaneous coronary intervention. Circulation Cardiovasc Interv 2009;2:213‑21.

Cruden NL, Harding SA, Flapan AD, Graham C, Wild SH, Slack R, et al. Scottish Coronary Revascularisation Register Steering Committee.Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circulation Cardiovasc Interv 2010;3:236‑42.

Hawn MT, Graham LA, Richman JR, Itani KM, Plomondon ME, Altom LK, et al. The incidence and timing of noncardiac surgery after cardiac stent implantation. J Am Coll Surg 2012;214:658‑66.

TCraft RM, Chavez JJ, Bresee DC, Wortham DC, Cohen E, Carroll RC. A novel modification of the thromboelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004;143:301‑9.